Home / News (Page 4)

News

Invectys starts the third dose level of its phase I ...

Invectys starts the third dose level of its phase I clinical trial evaluating INVAC-1, an innovative anti-cancer therapeutic vaccine  A new clinical hope in cancer…

Read more

Invectys raises 1.7 million Euros more to finance the ...

Invectys raises 1.7 million Euros more to  finance the clinical development of its therapeutic cancer vaccine With a total of 10 million euros raised, new premises,…

Read more

Invectys Initiates Phase I Clinical Trial Evaluating IN...

Invectys Initiates Phase I Clinical Trial Evaluating INVAC-1 Therapeutic Vaccine for Cancer Patients A new clinical hope in cancer immunotherapy Paris, May 12th,…

Read more

Invectys receives ANSM approval to start clinical trial...

Invectys receives ANSM approval to start clinical trial for INVAC-1, its leading anticancer immunotherapy INVAC-1 is an anticancer candidate vaccine targeting…

Read more

Press Release – Invectys Initiates Phase I Clinical T...

A new clinical hope in cancer immunotherapy Paris, May 12th, 2015 – Invectys announces today that it has initiated a phase I clinical trial of its immunotherapeutic…

Read more

Invectys publications

  A DNA telomerase vaccine for canine cancer immunotherapy Thalmensi J, Pliquet E, Liard C, Chamel G, Kreuz C, Bestetti T, Escande M, Kostrzac A, Pailhes-Jimenez…

Read more